A5101474242- Heart Failure Treatment and Management
- Cardiac pacing and defibrillation studies
- Cardiovascular Function and Risk Factors
- Cardiac Arrhythmias and Treatments
- Health Systems, Economic Evaluations, Quality of Life
- Blood Pressure and Hypertension Studies
- Statistical Methods in Clinical Trials
- Health and Medical Research Impacts
- Cardiac electrophysiology and arrhythmias
- Pulmonary Hypertension Research and Treatments
- Electrolyte and hormonal disorders
- Acute Myocardial Infarction Research
- Cardiac Structural Anomalies and Repair
- Potassium and Related Disorders
- Meta-analysis and systematic reviews
- Electronic Health Records Systems
- Ethics in Clinical Research
- Cardiac Valve Diseases and Treatments
- Pharmaceutical Practices and Patient Outcomes
- Nitric Oxide and Endothelin Effects
- Pharmaceutical Economics and Policy
- Cardiac Imaging and Diagnostics
- Pharmaceutical industry and healthcare
- Hemodynamic Monitoring and Therapy
- Diabetes Treatment and Management
Northwestern University
2008-2018
Harvard University
2013-2016
Brigham and Women's Hospital
2013-2016
Stony Brook University
2016
Emory University
2012-2013
Mayo Clinic
2013
Cleveland Clinic
2013
Scripps Clinic
2013
Duke Medical Center
2013
St Vincent Hospital
2013
Many clinical trials have demonstrated a benefit for cardiac resynchronization (CRT) and implantable cardioverter-defibrillator (ICD) therapies in patients with heart failure reduced ejection fraction, yet questions been raised regard to the of ICDs women. The purpose this study was determine effectiveness CRT ICD therapy as function sex outpatients fraction (≤35%).Data from Registry Improve Use Evidence-Based Heart Failure Therapies Outpatient Setting (IMPROVE HF) were analyzed by device...